Hawley Launches Investigations into Abortion Drug Makers Over 'Grave Risks' to Women

Senator Josh Hawley is launching investigations into two mifepristone manufacturers alleging they profited from the abortion drug despite posing 'grave risks' to women. The investigation targets companies that produce the medication, which was used in a 2022 Supreme Court decision striking down Roe v. Wade. Mifepristone has been linked to serious health complications, including blood clots and heart problems, according to Hawley's office. The senator is seeking more information on how these manufacturers marketed and sold the drug while potentially concealing its risks.